
EasyGop Buy Now Pay Later #BNPL
Patient affordability scoring technology enhancing access to treatment in emerging markets.
Date | Investors | Amount | Round |
---|---|---|---|
$570k | Seed | ||
Total Funding | 000k |
Related Content
MedScore is a FinTech SaaS company specializing in patient affordability scoring technology, primarily serving healthcare researchers and pharmaceutical companies in emerging markets, particularly in the Asia Pacific region. The company leverages artificial intelligence and advanced data analytics to streamline the patient evaluation process, ensuring timely access to critical treatments. MedScore's scalable digital platform allows for seamless deployment across various countries, maximizing program reach and efficiency. By utilizing geo-location intelligence and banking-level underwriting, MedScore enhances the accuracy of patient selection for access programs. The business model focuses on empowering patient access programs, with revenue generated through partnerships with pharmaceutical companies and healthcare providers. MedScore's solutions are designed to address the unique challenges of emerging markets, with a strong emphasis on localization and cultural understanding. The company's technology has been recognized by the Vietnam Ministry of Health, approving a patient access program for a breakthrough immunology cancer drug. Keywords: patient affordability, scoring technology, emerging markets, Asia Pacific, healthcare, pharmaceutical, AI, data analytics, patient access, localization.